Table 1.
Characteristics of the subjects selected for genotyping.
| Characteristics | TM group (n = 200) | Non-TM group (n = 200) | HC group (n = 76) | χ2 value | P-value |
|---|---|---|---|---|---|
| Gender | 4.48 | 0.11 | |||
| Male | 160 (80.0%) | 162 (81.0%) | 53 (69.7%) | ||
| Female | 40 (20.0%) | 38 (19.0%) | 23 (30.3%) | ||
| Age (years) | 2.59 | 0.63 | |||
| 18–45 | 157 (78.5%) | 148 (74.0%) | 54 (71.1%) | ||
| 46–65 | 41 (20.5%) | 49 (24.5%) | 20 (26.3%) | ||
| ≥66 | 2 (1.0%) | 3 (1.5%) | 2 (2.6%) | ||
| CD4+ T cell count (cells/ul) | 0.05 | 0.83 | |||
| 0–50 | 189 (94.5%) | 188 (94.0%) | NA | ||
| 51–100 | 11 (5.5%) | 12 (6.0%) | NA | ||
| Acute hepatitis co-infection | 2.62 | 0.11 | |||
| Yes | 34 (17.0%) | 47 (28.5%) | NA | ||
| No | 166 (83.0%) | 153 (71.5%) | NA | ||
| Other OIs co-infection | NA | NA | |||
| Yes | 200 (100.0%) | 200 (100.0%) | NA | ||
| No | 0 (0.0%) | 0 (0.0%) | NA |
TM group, AIDS patients with talaromycosis; Non-TM group, AIDS patients without talaromycosis; HC group, healthy controls group; OIs, opportunistic infections; NA, not applicable.